Jaume Català Mora
Investigador
Research group
Professional network profiles
Last Publications
- Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brenna RC, Burges M, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Catala J, Correa-Llano G, Carreras E and American Joint Committee on Cancer Ophthalmic Oncology Task Force Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology . 128(5): 740-753.
- Castany-Aregall M, Aparicio G, Grau N, Carceller A, Pérez-Hoyos S, Catala J and Anton A Angioid streaks and obstructive sleep apnea syndrome: are they related? SLEEP AND BREATHING . 25(1): 163-169.
- Mansour AM, Kozak I, Saatci AO, Ascaso FJ, Broc L, Battaglia M, Olivier N, Gili P, Chhablani J, Hedges TR, Honrubia A, Gutierrez L, Panozzo G, Catala J, Díaz J, Carreras E, Kadayifcilar S, Al Kahtani ES, Uwaydat SH, Lima LH, Mansour HA, Khan HA, Aaberg TM, Bovino JA and Hunyor AP Prepapillary vascular loop-a new classification. Eye . 35(2): 425-432.
News
-
A world-first treatment based on an oncolytic virus allows a child to overcome retinal cancer
The treatment, developed by researchers at Institut de Recerca Sant Joan de Déu, SJD Barcelona Children's Hospital and the biotechnology company VCN Biosciences has succeeded in preventing the child from going completely blind.